首页> 外文期刊>Journal of medical Internet research >Responding to Unsolicited Medical Requests from Health Care Professionals on Pharmaceutical Industry-Owned Social Media Sites: Three Pilot Studies
【24h】

Responding to Unsolicited Medical Requests from Health Care Professionals on Pharmaceutical Industry-Owned Social Media Sites: Three Pilot Studies

机译:响应医药行业拥有的社交媒体网站上医疗保健专业人员的主动提出的医疗请求:三个试点研究

获取原文
           

摘要

BackgroundThe use of social media has risen tremendously over the past decade with usage rates spanning from 5% American adults in 2005 up to 69% in 2016. A 2011 survey of 4033 clinicians found that 65% physicians use social media for professional purposes. To meet the changing needs and preferences of their customers, medical information departments within the pharmaceutical industry must continue to assess new digital channels such as social media and evolve their medical information services.ObjectiveThe objective of the study was to pilot the use of social media as an additional channel to respond to unsolicited medical requests from health care professionals (HCP RUR) directed toward the pharmaceutical industry.MethodsFrom November 2016 to June 2017, 3 pilots were conducted during 3 professional congresses: the 2016 American College of Rheumatology Annual Meeting, the 2017 American Society of Clinical Oncology Annual Meeting, and the 2017 American Headache Society Annual Scientific Meeting. For each social media account, an identified community manager monitored the incoming account feed for proper triaging of posts. When an unsolicited medical request appeared, the community manager routed the question to the Tier One medical information contact center agents to respond. The following metrics were collected: total number of unsolicited requests directed to medical information contact center agents, total number of unsolicited requests that required escalation to Tier Two medical information associates, total number of unsolicited requests that were confirmed US HCPs, total number of unsolicited requests received after hours, and total number of unsolicited requests that were redirected to a different channel.ResultsDuring the 3 pilots, 9 unsolicited medical requests were received with request numbers ranging from 2 to 4 requests per pilot. Of these, 1 was from a confirmed US HCP that required escalation to the Tier Two medical information associates. A majority of requests (7 out of 9) came in after the scheduled monitoring hours. There were 4 requests redirected to the medical information contact center phone number. The marketing accounts received more unsolicited medical requests than the corporate accounts (7 vs 2, respectively), and the 3 Twitter accounts saw more overall engagement (ie, medical requests and other general engagement) than the LinkedIn account.ConclusionsA limited number of medical questions were asked by confirmed HCPs using social media during the 3 pilots. New innovative medical information contact center channels often take time to build awareness. Continued channel awareness is needed to fully understand the channel’s desired use. Because consumers currently make up a majority of social media engagement, companies should look into creating a combined consumer and HCP RUR strategy to provide a better experience for all customers.
机译:背景信息过去十年中,社交媒体的使用量急剧增加,使用率从2005年的5%到2016年的69%于美国成年人。2011年对4033位临床医生的调查发现,有65%的医生将社交媒体用于专业目的。为了满足客户不断变化的需求和喜好,制药行业的医学信息部门必须继续评估新的数字渠道,例如社交媒体,并发展其医学信息服务。方法从2016年11月至2017年6月,在3次专业代表大会上进行了3次试点:2016年美国风湿病学会年会,2017年美国临床肿瘤学会年度会议,以及2017年美国头痛学会年度科学会议。对于每个社交媒体帐户,已确定的社区经理将监视传入的帐户供稿,以对帖子进行适当的分类。当出现不请自来的医疗请求时,社区经理将问题转给一级医疗信息联系中心代理商进行答复。收集了以下指标:向医疗信息联络中心代理人提出的未请求请求总数,需要升级到二级医疗信息助理的未请求请求总数,已确认的美国HCP主动请求请求总数,未请求请求总数在数小时后收到,并且主动将请求重定向到另一个通道的总数。结果在3位飞行员中,收到9个主动请求的医疗请求,每个飞行员的请求号范围为2到4。其中1个来自已确认的美国HCP,需要升级到二级医疗信息合作伙伴。大多数请求(9个中的7个)在计划的监视时间之后收到。有4个请求被重定向到医疗信息联系中心电话号码。营销帐户收到的主动请求的医疗请求要比公司帐户多(分别是7和2),并且3个Twitter帐户的整体参与度(即医疗请求和其他一般参与)比LinkedIn帐户要多。在3位飞行员中,确认的HCP使用社交媒体询问了他们。新的创新医疗信息联络中心渠道通常需要时间来建立知名度。需要持续的频道意识来完全了解频道的预期用途。由于消费者目前占社交媒体参与的大部分,因此公司应考虑创建消费者与HCP RUR的组合策略,以为所有客户提供更好的体验。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号